EXHEUSVITAL | ECONOMIC, LEGAL AND IP FEASIBILITY STUDIES OF EXHEUS VITAL TEST

Summary
Exheus VITAL is a unique, evidence-based innovative solution that supports HCPs in providing personalized treatment plans and recommendations to people suffering from obesity to effectively achieve weight management goals. The proprietary technology is based on individual’s gene activation analysis that is converted into insightful health intelligence reports which provide information on the health status of the individual, allow monitoring of patients’ over-time and a prognosis of possible pathologies. Exheus leads to unparalleled health outcomes, benefiting the individual and the society by driving cost-effectiveness of therapy.
Exheus VITAL offers advantages such as:
1.The information provided together by the RNA sequencing and by the Exheus AI technology allows to obtain precise information of the abnormalities in gene expression for each patient. This allow a high level of personalization that can’t be achieved with other methods to provide the best treatment for a given patient.
2.It allows to increase the adherence to the weight loss treatment increasing the effectiveness of the recommendations.
3.It helps HCPs motivate the patient and improve willingness to follow the health recommendations, therefore promoting a change in lifestyle habits sustainable over the time.
4.HCPs (i.e endocrinologist, primary care physicians) can now treat obesity through a clinically validated personalized medicine tool to guide and accompany the patient during its healthy weight loss process.
5.Monitoring the evolution of activated genes over time can be done through repeated tests to determine changes in these parameters.
Exheus VITAL is a fast, effective and attractive tool that helps Health Care Professionals (HCPs) to efficiently support patients with obesity in their weight loss goals. It has been demonstrated that the delivery of the scientifically proven insights (expression levels and changes) and recommendations using a digital method will be effective.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/101113870
Start date: 01-07-2023
End date: 31-12-2023
Total budget - Public funding: - 75 000,00 Euro
Cordis data

Original description

Exheus VITAL is a unique, evidence-based innovative solution that supports HCPs in providing personalized treatment plans and recommendations to people suffering from obesity to effectively achieve weight management goals. The proprietary technology is based on individual’s gene activation analysis that is converted into insightful health intelligence reports which provide information on the health status of the individual, allow monitoring of patients’ over-time and a prognosis of possible pathologies. Exheus leads to unparalleled health outcomes, benefiting the individual and the society by driving cost-effectiveness of therapy.
Exheus VITAL offers advantages such as:
1.The information provided together by the RNA sequencing and by the Exheus AI technology allows to obtain precise information of the abnormalities in gene expression for each patient. This allow a high level of personalization that can’t be achieved with other methods to provide the best treatment for a given patient.
2.It allows to increase the adherence to the weight loss treatment increasing the effectiveness of the recommendations.
3.It helps HCPs motivate the patient and improve willingness to follow the health recommendations, therefore promoting a change in lifestyle habits sustainable over the time.
4.HCPs (i.e endocrinologist, primary care physicians) can now treat obesity through a clinically validated personalized medicine tool to guide and accompany the patient during its healthy weight loss process.
5.Monitoring the evolution of activated genes over time can be done through repeated tests to determine changes in these parameters.
Exheus VITAL is a fast, effective and attractive tool that helps Health Care Professionals (HCPs) to efficiently support patients with obesity in their weight loss goals. It has been demonstrated that the delivery of the scientifically proven insights (expression levels and changes) and recommendations using a digital method will be effective.

Status

SIGNED

Call topic

HORIZON-EIE-2022-SCALEUP-02-02

Update Date

31-07-2023
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon Europe
HORIZON.3 Innovative Europe
HORIZON.3.2 European innovation ecosystems
HORIZON.3.2.0 Cross-cutting call topics
HORIZON-EIE-2022-SCALEUP-02
HORIZON-EIE-2022-SCALEUP-02-02 Women TechEU